Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02750865 · ClinicalTrials.gov registry record · NA
Conversational Agents to Improve Quality of Life in Palliative Care
A NA study of Palliative Care, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 367
- Enrollment target
- 1
- Study location
NCT02750865 is a NA study of Palliative Care that has completed, run by Boston Medical Center. The registered enrollment target is 367 participants, below the 1,396-participant average among 18 other Palliative Care trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02750865, a NA study of Palliative Care, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 367 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study the investigators will advance research on the development of easy to use technologies to empower patients. This is a scalable approach that has a significant potential to reduce suffering for palliative care patients and their caregivers. The investigators will adapt existing tested empathic conversational agents (ECA) for home-based cancer care management and inpatient bedside counseling to provide the following functions: 1. medication counseling; 2. physical activity promotion; 3. symptom management and continual screening for adverse events; and 4. alleviation of stress and anxiety 5. spiritual needs assessment; and 6. advanced care planning. Data from the system will be monitored by a health professional, who communicates with members of the patient's care team. In this project, this activity will include facilitating referral for palliative care services. The investigators will conduct pilot studies both at Boston Medical Center and at Northeastern University that will test system usability (Northeastern University and BMC) as well as interview burden (BMC only). The investigators will conduct a Randomized Control Trial (RCT) to evaluate the agent technology, comparing usual care (UC) versus usual care plus the agent (UC+ECA) for patients 21 or older, with a life expectancy of \< 1 year, from outpatient clinics at Boston Medical Center (BMC). Each subject will be enrolled along with a caregiver surrogate subject. In addition to baseline data collection, there will be monthly phone surveys for six months; intervention subjects will use the system for a six-month period of time. In addition, the investigators will conduct a randomized trial within the intervention group to compare subjects getting functions 1-4 (above) versus subjects getting the augmented intervention with all six functions. The intervention will include a nurse management interface to monitor clinical alerts generated by the system to stimulate interventions by the clinical
Conditions Studied
Interventions
- BEHAVIORAL Embodied Conversational Agent (ECA)
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 367 participants |
| Start Date | 2017-08-02 |
| Est. Completion | 2022-10-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02750865
The ClinicalTrials.gov registry entry for NCT02750865 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 367 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,396-participant average among 18 other Palliative Care trials with a reported enrollment target (74% lower). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Palliative Care appearing as the primary indexed condition, and to 1 intervention - of which Embodied Conversational Agent (ECA) is the first listed.
NCT02750865 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02750865 about?
NCT02750865 is a clinical study titled "Conversational Agents to Improve Quality of Life in Palliative Care". In this study the investigators will advance research on the development of easy to use technologies to empower patients. This is a scalable approach that has a significant potential to reduce suffering for palliative care patients and their caregivers. The investigators will adapt existing tested e...
What is the current status of trial NCT02750865?
This trial is currently completed. It is a NA study. The enrollment target is 367 participants. The study started on 2017-08-02. Estimated completion is 2022-10-24.
What conditions does trial NCT02750865 study?
This clinical trial studies the following conditions: Palliative Care.
What interventions are being tested in trial NCT02750865?
The interventions under investigation include: Embodied Conversational Agent (ECA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02750865?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02750865 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Palliative Care
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Needs Among Older Adults
RECRUITING · NA
-
Patient-centered, Optimal Integration of Survivorship and Palliative Care
RECRUITING · NA
-
E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
RECRUITING · NA
-
Comparing the Stanford Letter Project Form to Traditional Advance Directives
RECRUITING · NA
-
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
RECRUITING · NA
-
A Pragmatic Trial of an Active Choice Nudge for Generalist or Specialist Palliative Care for Seriously Ill Inpatients
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.